#ba4 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #ba4, aggregated by home.social.
-
#Clinical #profile analysis of #SARS-CoV-2 #community #infections during periods with #omicron #BA2, #BA4/5, and #XBB dominance in #HK: a prospective cohort study
Source: Lancet Infectious Diseases, SummaryBackgroundExisting studies on SARS-CoV-2 infection have mainly focused on severe clinical outcomes; understanding of the clinical severity profile of general community infections is poor. We aimed to assess and compare the clinical profiles of infections with…
-
#Clinical #profile analysis of #SARS-CoV-2 #community #infections during periods with #omicron #BA2, #BA4/5, and #XBB dominance in #HK: a prospective cohort study
Source: Lancet Infectious Diseases, SummaryBackgroundExisting studies on SARS-CoV-2 infection have mainly focused on severe clinical outcomes; understanding of the clinical severity profile of general community infections is poor. We aimed to assess and compare the clinical profiles of infections with…
-
#Clinical #profile analysis of #SARS-CoV-2 #community #infections during periods with #omicron #BA2, #BA4/5, and #XBB dominance in #HK: a prospective cohort study
Source: Lancet Infectious Diseases, SummaryBackgroundExisting studies on SARS-CoV-2 infection have mainly focused on severe clinical outcomes; understanding of the clinical severity profile of general community infections is poor. We aimed to assess and compare the clinical profiles of infections with…
-
#Clinical #profile analysis of #SARS-CoV-2 #community #infections during periods with #omicron #BA2, #BA4/5, and #XBB dominance in #HK: a prospective cohort study
Source: Lancet Infectious Diseases, SummaryBackgroundExisting studies on SARS-CoV-2 infection have mainly focused on severe clinical outcomes; understanding of the clinical severity profile of general community infections is poor. We aimed to assess and compare the clinical profiles of infections with…
-
#Clinical #profile analysis of #SARS-CoV-2 #community #infections during periods with #omicron #BA2, #BA4/5, and #XBB dominance in #HK: a prospective cohort study
Source: Lancet Infectious Diseases, SummaryBackgroundExisting studies on SARS-CoV-2 infection have mainly focused on severe clinical outcomes; understanding of the clinical severity profile of general community infections is poor. We aimed to assess and compare the clinical profiles of infections with…
-
#SARS-CoV-2 #BA4/5 #infection triggers more cross-reactive FcγRIIIa signaling and #neutralization than #BA1, in the context of #hybrid #immunity, J Virol.: https://journals.asm.org/doi/full/10.1128/jvi.00678-24?af=R
Although this is consistent with enhanced neutralization and FcγRIIIa signaling breadth of BA.4/5 vaccine boosters, the reduced activity against #XBB15 supports the need to update vaccines with XBB sublineage immunogens to provide adequate coverage of these highly antibody evasive variants.
-
#SARS-CoV-2 #BA4/5 #infection triggers more cross-reactive FcγRIIIa signaling and #neutralization than #BA1, in the context of #hybrid #immunity, J Virol.: https://journals.asm.org/doi/full/10.1128/jvi.00678-24?af=R
Although this is consistent with enhanced neutralization and FcγRIIIa signaling breadth of BA.4/5 vaccine boosters, the reduced activity against #XBB15 supports the need to update vaccines with XBB sublineage immunogens to provide adequate coverage of these highly antibody evasive variants.
-
#SARS-CoV-2 #BA4/5 #infection triggers more cross-reactive FcγRIIIa signaling and #neutralization than #BA1, in the context of #hybrid #immunity, J Virol.: https://journals.asm.org/doi/full/10.1128/jvi.00678-24?af=R
Although this is consistent with enhanced neutralization and FcγRIIIa signaling breadth of BA.4/5 vaccine boosters, the reduced activity against #XBB15 supports the need to update vaccines with XBB sublineage immunogens to provide adequate coverage of these highly antibody evasive variants.
-
#SARS-CoV-2 #BA4/5 #infection triggers more cross-reactive FcγRIIIa signaling and #neutralization than #BA1, in the context of #hybrid #immunity, J Virol.: https://journals.asm.org/doi/full/10.1128/jvi.00678-24?af=R
Although this is consistent with enhanced neutralization and FcγRIIIa signaling breadth of BA.4/5 vaccine boosters, the reduced activity against #XBB15 supports the need to update vaccines with XBB sublineage immunogens to provide adequate coverage of these highly antibody evasive variants.
-
#SARS-CoV-2 #BA4/5 #infection triggers more cross-reactive FcγRIIIa signaling and #neutralization than #BA1, in the context of #hybrid #immunity, J Virol.: https://journals.asm.org/doi/full/10.1128/jvi.00678-24?af=R
Although this is consistent with enhanced neutralization and FcγRIIIa signaling breadth of BA.4/5 vaccine boosters, the reduced activity against #XBB15 supports the need to update vaccines with XBB sublineage immunogens to provide adequate coverage of these highly antibody evasive variants.
-
#Protection against #SARS-CoV-2 #Omicron #BA4/5 variant following #booster #vaccination or breakthrough infection in the #UK https://www.nature.com/articles/s41467-023-38275-1
-
#Protection against #SARS-CoV-2 #Omicron #BA4/5 variant following #booster #vaccination or breakthrough infection in the #UK https://www.nature.com/articles/s41467-023-38275-1
-
#Protection against #SARS-CoV-2 #Omicron #BA4/5 variant following #booster #vaccination or breakthrough infection in the #UK https://www.nature.com/articles/s41467-023-38275-1
-
#mRNA #vaccines and hybrid #immunity use different B cell #germlines against #Omicron #BA4 and #BA5 https://www.nature.com/articles/s41467-023-37422-y
-
#mRNA #vaccines and hybrid #immunity use different B cell #germlines against #Omicron #BA4 and #BA5 https://www.nature.com/articles/s41467-023-37422-y
-
Association of #SARS-CoV-2 #BA4/BA.5 #Omicron lineages with immune escape and #clinical outcome https://www.nature.com/articles/s41467-023-37051-5
-
Association of #SARS-CoV-2 #BA4/BA.5 #Omicron lineages with immune escape and #clinical outcome https://www.nature.com/articles/s41467-023-37051-5
-
[Articles] Protective #immunity of #SARS-CoV-2 #infection and #vaccines against medically attended symptomatic #omicron #BA4, #BA5, and #XBB #reinfections in #Singapore: a national cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00060-9/fulltext?rss=yes
-
[Articles] Protective #immunity of #SARS-CoV-2 #infection and #vaccines against medically attended symptomatic #omicron #BA4, #BA5, and #XBB #reinfections in #Singapore: a national cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00060-9/fulltext?rss=yes
-
#Immunity of heterologous and homologous boosted or #convalescent individuals against #Omicron #BA1, #BA2 and #BA4/5 variants https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiad057/7069351?rss=1
-
#Immunity of heterologous and homologous boosted or #convalescent individuals against #Omicron #BA1, #BA2 and #BA4/5 variants https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiad057/7069351?rss=1
-
[Comment] Real-world #effectiveness of #nirmatrelvir–ritonavir against #BA4 and #BA5 #omicron #SARS-CoV-2 #variants https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00056-7/fulltext?rss=yes
-
[Comment] Real-world #effectiveness of #nirmatrelvir–ritonavir against #BA4 and #BA5 #omicron #SARS-CoV-2 #variants https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00056-7/fulltext?rss=yes
-
[Comment] Real-world #effectiveness of #nirmatrelvir–ritonavir against #BA4 and #BA5 #omicron #SARS-CoV-2 #variants https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00056-7/fulltext?rss=yes
-
[Articles] Real-world use of #nirmatrelvir–ritonavir in #outpatients with #COVID19 during the era of #omicron #variants including #BA4 and #BA5 in #Colorado, #USA: a retrospective cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00011-7/fulltext?rss=yes
-
[Articles] Real-world use of #nirmatrelvir–ritonavir in #outpatients with #COVID19 during the era of #omicron #variants including #BA4 and #BA5 in #Colorado, #USA: a retrospective cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00011-7/fulltext?rss=yes
-
[Articles] Real-world use of #nirmatrelvir–ritonavir in #outpatients with #COVID19 during the era of #omicron #variants including #BA4 and #BA5 in #Colorado, #USA: a retrospective cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00011-7/fulltext?rss=yes
-
[Articles] Real-world use of #nirmatrelvir–ritonavir in #outpatients with #COVID19 during the era of #omicron #variants including #BA4 and #BA5 in #Colorado, #USA: a retrospective cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00011-7/fulltext?rss=yes
-
[Articles] Real-world use of #nirmatrelvir–ritonavir in #outpatients with #COVID19 during the era of #omicron #variants including #BA4 and #BA5 in #Colorado, #USA: a retrospective cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00011-7/fulltext?rss=yes
-
#Protection conferred by #Delta and #BA1 / #BA2 #infection against #BA4 / #BA5 infection and #hospitalization: A Retrospective Cohort Study, The Journal of Infectious Diseases, jiad003, https://doi.org/10.1093/infdis/jiad003
-
Li, M., Ren, Y., Aw, Z.Q. et al. Broadly neutralizing and protective #nanobodies against #SARS-CoV-2 #Omicron subvariants #BA1, #BA2, and #BA4/5 and diverse #sarbecoviruses. Nat Commun 13, 7957 (2022). https://doi.org/10.1038/s41467-022-35642-2
-
Das ist, unabhängig von der/n Diskussion/Fragen um die immer noch nicht bekannte zeitliche Verfügbarkeit der [Original & Omicron #BA4/#BA5]-Booster (Zulassungen CH noch ausstehend) hochinteressant & positiv, da die Daten in relevantem Ausmass übertragbar sein dürften. 2/7
-
Das ist, unabhängig von der/n Diskussion/Fragen um die immer noch nicht bekannte zeitliche Verfügbarkeit der [Original & Omicron #BA4/#BA5]-Booster (Zulassungen CH noch ausstehend) hochinteressant & positiv, da die Daten in relevantem Ausmass übertragbar sein dürften. 2/7
-
Das ist, unabhängig von der/n Diskussion/Fragen um die immer noch nicht bekannte zeitliche Verfügbarkeit der [Original & Omicron #BA4/#BA5]-Booster (Zulassungen CH noch ausstehend) hochinteressant & positiv, da die Daten in relevantem Ausmass übertragbar sein dürften. 2/7
-
Das ist, unabhängig von der/n Diskussion/Fragen um die immer noch nicht bekannte zeitliche Verfügbarkeit der [Original & Omicron #BA4/#BA5]-Booster (Zulassungen CH noch ausstehend) hochinteressant & positiv, da die Daten in relevantem Ausmass übertragbar sein dürften. 2/7
-
Das ist, unabhängig von der/n Diskussion/Fragen um die immer noch nicht bekannte zeitliche Verfügbarkeit der [Original & Omicron #BA4/#BA5]-Booster (Zulassungen CH noch ausstehend) hochinteressant & positiv, da die Daten in relevantem Ausmass übertragbar sein dürften. 2/7
-
So, hier nun das Update: nachdem ich keinen Arzt gefunden hatte der mich ein 5. Mal impfen wollte, ging es nun endlich problemlos im #Impfzentrum #Bremen. Das ausschlaggebende Kriterium für war letztlich nur - 6 Monate Abstand zur vorherigen Impfung, sonst nichts (3 Monate zur Infektion wenn ich es richtig verstanden habe, aber da bin ich nicht sicher da nicht betroffen). #CovidIsNotOver #ImpfenSchützt #bivalent #BA4 #BA5 #Biontech #Moderna #ImpftDieKinder #FünfteImpfung #Booster
-
So, hier nun das Update: nachdem ich keinen Arzt gefunden hatte der mich ein 5. Mal impfen wollte, ging es nun endlich problemlos im #Impfzentrum #Bremen. Das ausschlaggebende Kriterium für war letztlich nur - 6 Monate Abstand zur vorherigen Impfung, sonst nichts (3 Monate zur Infektion wenn ich es richtig verstanden habe, aber da bin ich nicht sicher da nicht betroffen). #CovidIsNotOver #ImpfenSchützt #bivalent #BA4 #BA5 #Biontech #Moderna #ImpftDieKinder #FünfteImpfung #Booster
-
@Der_Waeller Was ich mich frage, werden die aktuell überhaupt noch in der Breite getestet? Womit?
"Nur" RSV als Folge von Covid19, oder doch zum Teil Covid19 selbst, Runde 3 - 4?
Kenne selbst 2 Personen mit Symptomen, AG-negativ, die wurden vom Arzt weggeschickt "is' sicher kein Corona", ohne PCR ... beide lebten jedoch in einem Haushalt mit einer AG-positiven Person. Was passiert da draußen?
#CovidIsNotOver #FifthShot #BA4 #BA5 #ImpfenSchuetzt #ImpftDieKinder #Booster
-
@Der_Waeller Was ich mich frage, werden die aktuell überhaupt noch in der Breite getestet? Womit?
"Nur" RSV als Folge von Covid19, oder doch zum Teil Covid19 selbst, Runde 3 - 4?
Kenne selbst 2 Personen mit Symptomen, AG-negativ, die wurden vom Arzt weggeschickt "is' sicher kein Corona", ohne PCR ... beide lebten jedoch in einem Haushalt mit einer AG-positiven Person. Was passiert da draußen?
#CovidIsNotOver #FifthShot #BA4 #BA5 #ImpfenSchuetzt #ImpftDieKinder #Booster
-
@Der_Waeller Was ich mich frage, werden die aktuell überhaupt noch in der Breite getestet? Womit?
"Nur" RSV als Folge von Covid19, oder doch zum Teil Covid19 selbst, Runde 3 - 4?
Kenne selbst 2 Personen mit Symptomen, AG-negativ, die wurden vom Arzt weggeschickt "is' sicher kein Corona", ohne PCR ... beide lebten jedoch in einem Haushalt mit einer AG-positiven Person. Was passiert da draußen?
#CovidIsNotOver #FifthShot #BA4 #BA5 #ImpfenSchuetzt #ImpftDieKinder #Booster
-
@Der_Waeller Was ich mich frage, werden die aktuell überhaupt noch in der Breite getestet? Womit?
"Nur" RSV als Folge von Covid19, oder doch zum Teil Covid19 selbst, Runde 3 - 4?
Kenne selbst 2 Personen mit Symptomen, AG-negativ, die wurden vom Arzt weggeschickt "is' sicher kein Corona", ohne PCR ... beide lebten jedoch in einem Haushalt mit einer AG-positiven Person. Was passiert da draußen?
#CovidIsNotOver #FifthShot #BA4 #BA5 #ImpfenSchuetzt #ImpftDieKinder #Booster
-
Ju, B., Fan, Q., Wang, M. et al. #Antigenic sin of wild-type #SARS-CoV-2 #vaccine shapes poor cross- #neutralization of #BA4/5/2.75 #subvariants in #BA2 breakthrough infections. Nat Commun 13, 7120 (2022). https://doi.org/10.1038/s41467-022-34400-8